Winslow Evans & Crocker’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Winslow Evans & Crocker’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$5K	Buy	+90	New	+$5.13K	﹤0.01%	1086

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Winslow Evans & Crocker's IHE Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q4 2020: 90 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #1086 among its holdings.

99 funds tracked by Wall St. Rank hold IHE as of Q4 2020.

Winslow Evans & Crocker held 90 shares of iShares US Pharmaceuticals ETF worth $5K as of Q4 2020.
iShares US Pharmaceuticals ETF was a new Winslow Evans & Crocker position in Q4 2020.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1086 holding.
99 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.